RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Barriers, facilitators, and potential solutions to advancing interoperable Clinical Decision Support
Multi-stakeholder consensus recommendations for the opioid use case
Marcial, L. H., Blumenfeld, B., Harle, C., Jing, X., Keller, M. S., Lee, V., Lin, Z., Dover, A., Midboe, A. M., Al-Showk, S., Bradley, V., Breen, J., Fadden, M., Lomotan, E., Marco-Ruiz, L., Mohamed, R., O'Connor, P., Rosendale, D., Solomon, H., & Kawamoto, K. (2019). Barriers, facilitators, and potential solutions to advancing interoperable Clinical Decision Support: Multi-stakeholder consensus recommendations for the opioid use case. AMIA Annual Symposium Proceedings, 2019, 637-646. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153100/
With the advent of interoperability standards such as FHIR, SMART, CDS Hooks, and CQL, interoperable clinical decision support (CDS) holds great promise for improving healthcare. In 2018, the Agency for Healthcare Research and Quality (AHRQ)-sponsored Patient-Centered CDS Learning Network (PCCDS LN) chartered a Technical Framework Working Group (TechFWG) to identify barriers, facilitators, and potential solutions for interoperable CDS, with a specific focus on addressing the opioid epidemic. Through an open, multi-stakeholder process that engaged 54 representatives from healthcare, industry, and academia, the TechFWG identified barriers in 6 categories: regulatory environment, data integration, scalability, business case, effective and useful CDS, and care planning and coordination. Facilitators and key recommendations were also identified for overcoming these barriers. The key insights were also extrapolated to CDS-facilitated care improvement outside of the specific opioid use case. If applied broadly, the recommendations should help advance the availability and impact of interoperable CDS delivered at scale.
